Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03363867
Title BEACON - ABC in Recurrent Platinum Resistant HGSOC (BEACON)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors Peter MacCallum Cancer Centre, Australia
Indications

peritoneum cancer

fallopian tube cancer

ovarian serous carcinoma

Therapies

Atezolizumab + Bevacizumab + Cobimetinib

Age Groups: adult | senior
Covered Countries

Additional content available in CKB BOOST